Overview: HSB 151, a bill for an act relating to nonopioid drugs on the medical assistance preferred drug list, and health carriers' development of a pain management access plan, was introduced on February 11, 2025 and has been recommended for passage by a subcommittee.
Purpose and Intent: The bill aims to address the opioid crisis by promoting the use of non-opioid pain management alternatives and improving access to comprehensive pain treatment options for Medicaid recipients.
Key Provisions:
- Requires the Iowa Medicaid program to include non-opioid drugs on the preferred drug list, ensuring better coverage and accessibility for Medicaid beneficiaries.
- Mandates that health insurance carriers develop and implement a pain management access plan, which must include coverage for non-opioid pain treatments and coordination with providers to offer comprehensive pain management services.
- Directs the Iowa Department of Human Services to conduct an annual review of the preferred drug list and pain management access plans to ensure they remain up-to-date and effective.
Affected Parties and Impacts: The bill would primarily benefit Medicaid recipients and individuals covered by private health insurance plans. By increasing access to non-opioid pain management options, the legislation could help reduce opioid misuse and overdoses, leading to improved health outcomes and reduced healthcare costs.
Procedural and Timeline Considerations: HSB 151 has been recommended for passage by a subcommittee, indicating progress in the legislative process. The next step would be consideration by the full committee, followed by potential action in the House and Senate, and ultimately the governor's signature to enact the law.
